Parkinson's Disease News and Research

RSS
Parkinson's disease is a brain disorder. It occurs when certain nerve cells (neurons) in a part of the brain called the substantia nigra die or become impaired. When approximately 80 percent of neurons are damaged, the symptoms of Parkinson's disease appear. Parkinson's disease affects 1 in 100 people over the age of 60, with the average age of onset being 60 years. The risk of developing Parkinson's disease increases with age. In the United States, it is estimated that 60,000 new cases of Parkinson's disease are diagnosed each year, with 1.5 million Americans currently living with the disease.
Antisense Therapy Shows Promise Against Parkinson's

Antisense Therapy Shows Promise Against Parkinson's

New Research Highlights Brain Connectivity as Key Factor in Cognitive Aging

New Research Highlights Brain Connectivity as Key Factor in Cognitive Aging

Macrophage Inflammation may Contribute to LSD Symptoms

Macrophage Inflammation may Contribute to LSD Symptoms

Novel protein biomarker panel can detect Parkinson's disease in early stages using blood samples

Novel protein biomarker panel can detect Parkinson's disease in early stages using blood samples

Dundee Scientists Reveal Inner Workings of PINK1 Molecular Switch in Parkinson's Disease

Dundee Scientists Reveal Inner Workings of PINK1 Molecular Switch in Parkinson's Disease

New Light-Sensitive Proteins Unlock Brain Cell Control for Neurological Research

New Light-Sensitive Proteins Unlock Brain Cell Control for Neurological Research

Sonification Reveals Hidden Patterns in Protein Folding Dynamics

Sonification Reveals Hidden Patterns in Protein Folding Dynamics

Epigenomic Analysis Reveals Potential Treatment Avenues for ALS

Epigenomic Analysis Reveals Potential Treatment Avenues for ALS

Unveiling Cannabinoid’s Potential for Treating Age-Related Brain Degeneration

Unveiling Cannabinoid’s Potential for Treating Age-Related Brain Degeneration

Mapping Gene Signatures Unveils How Lewy Bodies Impact Brain Cells

Mapping Gene Signatures Unveils How Lewy Bodies Impact Brain Cells

New Model Captures Multiple Factors Driving Alpha-Synuclein Aggregation

New Model Captures Multiple Factors Driving Alpha-Synuclein Aggregation

Uncovering How to Protect Nerves in Neurodegenerative Diseases

Uncovering How to Protect Nerves in Neurodegenerative Diseases

New Technology Enables Minimally-Invasive, High-Resolution Recording of Brain Activity

New Technology Enables Minimally-Invasive, High-Resolution Recording of Brain Activity

Exploring the Dual Role of Phosphorylated α-Synuclein in Healthy Neural Function

Exploring the Dual Role of Phosphorylated α-Synuclein in Healthy Neural Function

Genetic Twist in Tiny Protein Protects Against Parkinson's

Genetic Twist in Tiny Protein Protects Against Parkinson's

Scientists Unravel the Mystery of Parkinson's Disease With 3D Protein Structures

Scientists Unravel the Mystery of Parkinson's Disease With 3D Protein Structures

NEMO Protein Promotes Degradation of Harmful Alpha-Synuclein Aggregates in Parkinson's Disease

NEMO Protein Promotes Degradation of Harmful Alpha-Synuclein Aggregates in Parkinson's Disease

Misfolded Proteins: How They Damage Neurons and Cause Neurodegeneration

Misfolded Proteins: How They Damage Neurons and Cause Neurodegeneration

New Drug-Like Molecule Enhances Mitophagy, Protects Against Neurodegeneration

New Drug-Like Molecule Enhances Mitophagy, Protects Against Neurodegeneration

Novel Gene Therapy Targets Core Motor Symptoms of Parkinson’s Disease

Novel Gene Therapy Targets Core Motor Symptoms of Parkinson’s Disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.